Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Basic toxicokinetics

Currently viewing:

Administrative data

Endpoint:
basic toxicokinetics
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)

Data source

Reference
Reference Type:
publication
Title:
Comparative Metabolism and Excretion of Resorcinol in Male and female F344 Rats
Author:
Kim YC, Matthews HB
Year:
1987
Bibliographic source:
Fundam Appl Toxicol 9 (3): 409-14 (l987)

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other:
GLP compliance:
not specified

Test material

Constituent 1
Reference substance name:
Resorcinol
Cas Number:
Resorcinol
Molecular formula:
C6H6O2
IUPAC Name:
Resorcinol
Constituent 2
Reference substance name:
1,3-Benzenediol
Cas Number:
108-46-3
Molecular formula:
C6H6O2
IUPAC Name:
1,3-Benzenediol
Constituent 3
Chemical structure
Reference substance name:
Resorcinol
EC Number:
203-585-2
EC Name:
Resorcinol
Cas Number:
108-46-3
Molecular formula:
C6H6O2
IUPAC Name:
1,3 benzenediol
Details on test material:
- Name of test material (as cited in study report): (14)C resorcinol
- Molecular formula (if other than submission substance): C6H6O2
- Molecular weight (if other than submission substance): 110.1 g/mol
- Substance type: Organic
- Physical state: Solid
Radiolabelling:
not specified

Test animals

Species:
rat
Strain:
Fischer 344
Sex:
male/female

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
unchanged (no vehicle)
Details on exposure:
A dose of 112 mg/kg of (14)C resorcinol was orally administered to 3 male and 3 female Fischer 344 rats. After one day, the animals were sacrificed, and major tissues and excretory products were analyzed to determine the fate of the resorcinol.
Duration and frequency of treatment / exposure:
24 hours
Doses / concentrations
Remarks:
Doses / Concentrations:
A single dose of 112 mg/kg of (14)C resorcinol
No. of animals per sex per dose / concentration:
3
Control animals:
not specified

Results and discussion

Main ADME resultsopen allclose all
Type:
absorption
Results:
Following oral administration, resorcinol was readily absorbed from the gastrointestinal tract
Type:
distribution
Results:
Resorcinol was seen to undergo enterohepatic circulation after administration
Type:
metabolism
Results:
Less than 50% of the parent compound was excreted in the urine, most was in the form of four metabolites. The major metabolite of resorcinol was a glucuronide conjugate (approximately 70%). One metabolite was identified as a sulfate conjugate (10-20%)
Type:
metabolism
Results:
one was identified as a diconjugate with glucuronide and sulfate (5-10%), and one, present in small quantities (less than 2%), was suggested to be a diglucuronide conjugate.
Type:
excretion
Results:
More than 90% of the total administered dose was recovered from the excreta in 24 hr. The primary route of excretion was in the urine. Only 1 to 2% of the dose was eliminated in the feces and less than 0.1% was eliminated as CO2.
Type:
excretion
Results:
Cannulation of the common bile duct followed by iv injection of 11.2 mg/kg resorcinol indicated that excretion in bile was rapid and underwent enterohepatic circulation to be excreted in the urine.

Metabolite characterisation studies

Metabolites identified:
yes
Details on metabolites:
glucuronide conjugate
sulfate conjugate
diconjugate with glucuronide and sulfate
diglucuronide conjugate

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information): low bioaccumulation potential based on study results
From the above information on absorption, distribution, metabolism and excretion of resorcinol; the bio-accumulation potential of the chemical appears to be low.
Executive summary:

In a 24 hour study with male and female Fisher 344 rats that were given a single oral dose of 112 mg/kg of (14)C resorcinol, more than 90% of the total administered dose was recovered from the excreta in 24 hrindicating little potential for bioaccumulation in animal tissues.Only trace amounts of the compound were found in any tissue and there was no evidence of specific organ accumulation